A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics
Clinical trial NCT02547870 · COMPLETED
Trial details
- NCT number
- NCT02547870
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-14
- Primary completion
- 2016-04-26
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.